The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis
Abstract
The authors constructed a Markov model as part of a systematic review of cervical cytology conducted at the Duke University Evidence-based Practice Center (Durham, North Carolina) between October 1997 and September 1998. The model incorporated states for human papillomavirus infection (HPV), low- and high-grade squamous intraepithelial lesions, and cervical cancer stages I-IV to simulate the natural history of HPV infection in a cohort of women from ages 15 to 85 years. The age-specific incidence rate of HPV, and regression and progression rates of HPV and squamous intraepithelial lesions, were obtained from the literature. The effects of varying natural history parameters on cervical cancer incidence were evaluated by using sensitivity analysis. The base-case model resulted in a lifetime cervical cancer risk of 3.67% and a lifetime cervical cancer mortality risk of 1.26%, with a peak incidence of 81/100,000 at age 50 years. Age-specific distributions of precursors were similar to reported data. Lifetime risk of cancer was most sensitive to the incidence of HPV and the probability of rapid HPV progression to high-grade lesions (two- to threefold variations in risk). The model approximates the age-specific incidence of cervical cancer and provides a tool for evaluating the natural history of HPV infection and cervical cancer carcinogenesis as well as the effectiveness and cost-effectiveness of primary and secondary prevention strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to unavailability of any empirically derived estimates on the natural history of progression in undiagnosed cases of cancer as well as their probability of showing symptoms from India, parameter values derived from a mathematical model developed by Myers et al were used. [16]”
From Cost effectiveness of strategies for cervical cancer prevention in India (2020) · cites this paper as [16]
Citations
Cites
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
SCHIFFMAN, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,197
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, L. A. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,103
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J. A., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 940
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-214 · Cited by 841
Meta-analysis of Pap Test Accuracy
Fahey, M. T., Irwig, L., & Macaskill, P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117485 · Cited by 690
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., SCHIFFMAN, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Quinn, M. A., Babb, P., Jones, J., & Allen, E. (1999) · BMJ · doi:10.1136/bmj.318.7188.904 · Cited by 571
Moscicki, A., Shiboski, S. C., Broering, J. M., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R. J., Kanowitz, S., Miller, S., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 562
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Sexually Transmitted Diseases Treatment Guidelines, 2010
Workowski, K., & BOLAN, G. A. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,074
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H. W., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,873
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S. M., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3600604 · Cited by 1,573
Sexually Transmitted Infections Among US Women and Men
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J. R., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,281
Metadata
- Authors
- Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B.
- Affiliations
- Duke University (US)
- Corresponding author
- Myers, E. R.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-06-15
- Volume
- 151
- Issue
- 12
- Pages
- 1158-1171
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2113839478
- Cited by
- 470
- References
- 49
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 8 · 2023: 14 · 2022: 13 · 2021: 17 · 2020: 18 · 2019: 11 · 2018: 19 · 2017: 20 · 2016: 12 · 2015: 22 · 2014: 24 · 2013: 32 · 2012: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (290-97-0014)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- HPV infection, cervical carcinogenesis, natural history of HPV infection, squamous intraepithelial lesions, cervical cancer incidence, cervical cancer mortality, lifetime cancer risk, Markov model, cervical cancer prevention, sensitivity analysis
- MeSH terms
- Adolescent, Adult, Aged, Antiviral Agents, Cell Transformation, Neoplastic, Uterine Cervical Neoplasms, Cost-Benefit Analysis, Female, Humans, Markov Chains, Middle Aged, Models, Theoretical, Tumor Virus Infections, Incidence, Risk Assessment, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
